CD4 and lymphopenia: Although absolute lymphocyte count differed in our patients, additional analysis of lymphocyte subtypes confirmed that CD4+ T cells and CD19+ B cells were decreased at a comparable level with narrow intra- and inter-individual variation in all fingolimod treated patients irrespective of the degree of lymphopenia.